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Abstract
Background: Whereas the role played by interleukin (IL)-10 in modulating fever and sickness behavior has been
linked to it targeting the production of pro-inflammatory cytokines in the circulation, liver and spleen, it is not
known whether it could directly target the local production of pro-inflammatory cytokines within the sensory
circumventricular organs (CVOs) situated within the brain, but outside the blood–brain barrier. Using inactivation of
IL-10, we, therefore, investigated whether IL-10 could modulate the synthesis of pro-inflammatory cytokines within
the sensory CVOs, in particular the organum vasculosum laminae terminalis (OVLT) and area postrema (AP).
Findings: Primary OVLT and AP microcultures were established from topographically excised rat pup brain tissue.
The microcultures were pretreated with either IL-10 antibodies (AB) (10 μl/350 μl medium) or phosphate-buffered
saline (PBS) (10 μl/350 μl medium) before being incubated with lipopolysaccharide (LPS) (100 μg/ml) or PBS in
complete medium for 6 h. Supernatants were removed from the microcultures after 6 h of incubation with LPS and
used for the determination of IL-6 and tumor necrosis factor (TNF)-α. Pre-treating the OVLT and AP microcultures
with IL-10 antibodies significantly enhanced the LPS-induced increase in TNF-α and IL-6 in the supernatant
obtained from the microcultures.
Conclusions: Our results show for the first time that the LPS-induced release of pro-inflammatory cytokines in cells
cultured from the AP and OVLT can be modulated in the presence of IL-10 antibodies. Thus, we have identified
that the sensory CVOs may have a key role to play in both the initiation and modulation of neuroinflammation.
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Findings
Results obtained from studies using interleukin (IL)-10 an-
tagonism to block the action of endogenous IL-10 in animal
models of systemic and local infection or inflammation
induced by lipopolysaccharide (LPS) administration have
provided convincing evidence which links the role played
by IL-10 in modulating fever and sickness behavior to it
suppressing the synthesis of key mediators known to induce
sickness responses, namely pro-inflammatory cytokines
[1-3]. Increased concentrations of pro-inflammatory cyto-
kines have been detected in the periphery and the brain in
response to a peripheral immune challenge [3]. Whereas it
has been shown that IL-10 can inhibit the peripheral syn-
thesis of pro-inflammatory cytokines by targeting immune
cells present in the circulation, liver and spleen [2,4], it is
yet to be established whether IL-10 can also inhibit the
local production of pro-inflammatory cytokines within the
sensory circumventricular organs (CVOs) [5-8]. The CVOs
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are specialized brain regions that lack a tight blood–brain
barrier and are, therefore, directly exposed to circulating
molecules, such as IL-10 [9]. Moreover, they have been
shown to contain glial cells known to express receptors for
IL-10 [10]. Thus, to determine if the sensory CVOs, in
particular the organum vasculosum laminae terminalis
(OVLT) and area postrema (AP), are possible central tar-
gets whereby IL-10 could modulate the synthesis of brain-
intrinsic pro-inflammatory cytokines, we have chosen to
investigate the consequences of inactivation of IL-10 on the
LPS-induced production of pro-inflammatory cytokines, in
particular tumor necrosis factor (TNF)-α and IL-6, in the
supernatant obtained from OVLTand AP microcultures.
Wistar rat pups of both sexes obtained from an in-
house breeding colony with parent animals obtained
from Charles River WIGA (Sulzfeld, Germany) were used
for the experiments. The pups were housed with their
mothers in a temperature-controlled room (24 ± 1°C) with
relative humidity at 50%, and a 12 h:12 h light:dark cycle
(lights on 07:00 local time). All procedures were approved
by the Hessian Animal Ethics Committee (ethics approval
number 527_AZ).
As previously described [5-8], primary microcultures of
the rat OVLT and AP were established from topographic-
ally excised brain tissue of four- to six-day-old Wistar rat
pups. The dissociated OVLT and AP cells were plated onto
pre-warmed, poly-L-lysine (1.0 mg/ml H2O; Sigma–
Aldrich GmbH, Munich, Germany) coated CELLocateW
glass coverslips (Eppendorf GmbH, Hamburg, Germany)
forming the bottom of a reusable Flexiperm-micro-12
well (6 mm diameter; Greiner Bio-One GmbH, Solingen,
Germany), to ensure sufficient cell density, despite limited
absolute cell number. Cells were cultured in a humidified
atmosphere of 5% CO2 and 95% air at 37.0°C. The medium
was exchanged the next day to remove cellular debris and
thereafter every two days during the culture period.
Lipopolysaccharide (LPS) derived from Escherichia coli
endotoxin (serotype, 0111:B4, Sigma-Aldrich GmbH,
Munich, Germany) was reconstituted in sterile pyrogen-
free 0.9% phosphate-buffered saline (PBS, Dulbecco’s,
PAA Laboratories GmbH, D-Cölbe, Germany ) at a con-
centration of 1 mg/ml and added to the microculture by
a bolus application to achieve a final concentration of
100 ug/ml. The IL-10 antibodies (IL-10AB) used in the
primary microculture experiments (S2503BM, National
Institute for Biological Standards and Control, South
Mimms, Potters Bar, Herts, UK) were purified by ammo-
nium sulphate precipitation of sheep immunoglobulin G
(IgG) followed by bulk ion exchange purification for a
final concentration of 1 mg/ml sheep IgG and stored at
−80°C until use. The antibodies were raised in sheep as
previously described [11]. The neutralizing ability of the
IL-10AB on rat IL-10 has been confirmed in previous
in vitro and in vivo studies [2,11]. The specificity of the
IL-10AB was determined in vitro using a two-site sandwich
ELISA, as described previously [11], and shown to be spe-
cific to rat IL-10 and not cross-react with the following rat
recombinant cytokines: (rr) TNF-α, IL-6 and IL-1β.
Supernatants removed from the microcultures were
used for the determination of IL-6 and TNF-α. Deter-
mination of TNF-α was performed by a bioassay based
on the cytotoxic effect of TNF-α on the mouse fibrosar-
coma cell line WEHI 164 subclone 13 and a murine
TNF-α standard (code 88/532; National Institute for Bio-
logical Standards and Control, South Mimms, UK) [5].
Measurement of IL-6 was performed by a bioassay based
on a dose-dependent growth stimulation of IL-6 on the
B9 hybridoma cell line and a human IL-6 standard
(code89/548; National Institute of Standards and Con-
trol, South Mimms, UK) [5]. The levels of TNF-α and
IL-6, which we determined in our samples, do not reflect
absolute cytokine concentrations, but rather bioactivity
in relation to established international standards.
After four to six days of cultivation on CELLocateW glass
coverslips (Eppendorf GmbH, Hamburg, Germany), the
OVLT and AP cells were incubated with LPS (100 μg/ml)
or PBS in complete medium for 6 h in a humidified
atmosphere of 5% CO2 and 95% air at 37.0°C. In addition,
cells were pretreated 30 minutes before with either IL-
10AB (10 μl) or PBS (10 μl). Some wells received no treat-
ment/stimulation to control for basal cytokine levels. In
pilot experiments, we tested several doses of the IL-10AB
(1, 5, 10 μl of IL-10AB added to 350 μl of medium at an
initial concentration of 1 mg/ml, for example, at final
concentrations of approximately 3 μg/ml, approximately
15 μg/ml or approximately 30 μg/ml) and determined
30 μg/ml to be the most effective concentration. The time
interval and dose of LPS we used, has previously been
shown to induce robust increases in TNF-α and IL-6 in
the supernatant [5,7]. After the 6 h incubation, the super-
natants were removed from the cells, transferred and
stored at −45°C for later determination of cytokines.
Cytokine levels were compared using a one-way ana-
lysis of variance (ANOVA). A Student-Newman-Keul’s
(SNK) post hoc test was used to detect differences be-
tween groups when the ANOVA detected significant
main effects or interactions. Where cytokine levels were
undetectable; samples were assigned a value equivalent
to the detection limit of the assay. The cytokine data
were not normally distributed and, therefore, log trans-
formed before being analyzed using a one-way ANOVA.
The data presented are non-transformed means ± stand-
ard deviations (SD), but the associated significance
values were derived from log transformed data. A two-
tailed probability of P <0.05 was considered statistically
significant.
Figures 1 and 2 show that there was a significant in-
crease in the levels of TNF-α and IL-6 in OVLT and AP
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microcultures treated with LPS compared to cultures
receiving no treatment. Pre-treating the OVLT and AP
microcultures with IL-10 antibodies significantly enhanced
the LPS-induced increase in TNF-α (P <0.05, SNK) and
IL-6 (P <0.05, SNK). The IL-10 antibodies alone had no ef-
fect on the cytokine levels in the OVLT and AP microcul-
tures, as no significant differences were found between the
cultures treated with the IL-10 antibody and PBS and the
cultures receiving no treatment (P >0.05).
We have shown that inactivation of IL-10 significantly
enhanced the LPS-induced release of TNF-α and IL-6
into the supernatant of OVLT and AP microcultures.
Thus, it appears that IL-10 has a role to play in modulat-
ing the synthesis of pro-inflammatory cytokines within
these two specific sensory CVOs. Using immunolabeling
with polyclonal antisera and monoclonal antibodies
directed against cell-specific marker proteins we have
previously characterized the cellular phenotypes present
in the OVLT and AP [5,7]. Both the OVLT and AP ap-
pear to contain small-sized bi- or tripolar neurons, squa-
mous or stellae astrocytes, mature oligodendrocytes and
microglial cells [5,7]. Using primary rat or mice cultures
others have identified that astrocytes, oligodendrocytes
and microglial cells express IL-10 receptors [10,12,13].
Due to the absence of a tight blood–brain barrier within
OVLT and AP it is thus possible that IL-10 released into
the circulation in response to a peripheral immune chal-
lenge could act on the above mentioned cells to modu-
late the local production of pro-inflammatory cytokines
within these specialized brain regions. It has been pro-
posed that pro-inflammatory cytokines produced within
the OVLT and AP could be involved in regulating sick-
ness responses, (in particular, fever and anorexia), by
acting either directly or indirectly on hypothalamic
Figure 1 TNF-α and IL-6 concentrations in supernatants of
OVLT microcultures. The microcultures were treated with IL-10AB
or PBS 30 minutes before LPS or PBS. The supernatants of the OVLT
microcultures were collected 6 h after treatment with LPS (final
concentration: 100 μg/ml) or PBS, and concentrations of TNF-α (A)
and IL-6 (B) were determined by specific bioassays. Columns
represent means with SD (n = 11–23). * Significant differences
between microcultures treated with LPS + PBS vs LPS + IL-10AB. #
Significant differences between microcultures treated with PBS +
IL-10AB vs LPS + PBS and LPS + IL-10AB. + Significant differences
between microcultures receiving no treatment vs LPS + PBS and
LPS + IL-10AB. No significant differences were noted between
microcultures receiving no treatment and microcultures treated with
PBS + IL-10AB.
Figure 2 TNF-α and IL-6 concentrations in supernatants of AP
microcultures. The microcultures were treated with IL-10AB or PBS
30 minutes before LPS or PBS. The supernatants of the AP
microcultures were collected 6 h after stimulation with LPS (final
concentration: 100 μg/ml) or PBS, and concentrations of TNF-α (A)
and IL-6 (B) were determined by specific bioassays. Columns
represent means with SD (n = 11 to 23). * Significant differences
between microcultures treated with LPS + PBS vs LPS + IL-10AB. #
Significant differences between microcultures treated with PBS +
IL-10AB vs LPS + PBS and LPS + IL-10AB. + Significant differences
between microcultures receiving no treatment vs LPS + PBS and
LPS + IL-10AB. No significant differences were noted between
microcultures receiving no treatment and microcultures treated with
PBS + IL-10AB.
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neural circuits believed to be involved in regulating body
temperature and appetite [9,14,15]. Thus, IL-10 could
modulate the activation of the hypothalamus and in turn
the ensuing sickness responses initiated by the hypothal-
amus in response to a peripheral immune challenge, by
not only modulating the production of pro-inflammatory
cytokines in the periphery, but also at the interface be-
tween the periphery and the brain, namely the sensory
CVOs [1-3]. By modulating the pool of pro-inflammatory
cytokines synthesized by the sensory CVOs, IL-10 could
thus play an important role in modulating the duration of
sickness responses associated with infection or inflamma-
tion, as we and others have shown that the induction of
pro-inflammatory cytokines within the brain is a key event
in the prolongation of illness-associated fever, anorexia
and lethargy [16-18].
Our results show for the first time that the LPS-
induced release of pro-inflammatory cytokines in cells
cultured from the AP and OVLT can be modulated in
the presence of IL-10 antibodies. We have, therefore,
identified that the sensory CVOs, situated at the inter-
face between the periphery and the brain, appear to have
an important role to play in modulating neuroinflamma-
tion and, thus, the initiation, development and progres-
sion of some neurological diseases may be related to the
disruption of the anti-inflammatory actions of these
organs.
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